Capsaicin [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Capsaicin ======

Drug info: Capsaicin ([[Zostrix]]®)

A vanillyl alkaloid derived from hot peppers, available without a prescription for topical treatment of
the pain of [[herpes zoster]] and [[diabetic neuropathy]]. Beneficial in some patients with either of these
conditions (response rate at 8 weeks was 90% for PHN, 71% for diabetic neuropathy, vs. 50% with
placebo in either group), although the high placebo response rate is disturbing and many authorities are skeptical
((Capsaicin - A Topical Analgesic. Med Letter. 1992; 34:62–63)).

Expensive. Side effects: include burning and erythema at the application site (usually subsides by 2–4 weeks).

℞ Manufacturer recommends massaging the medication into the affected area of the skin TID-QID (apply a very thin coat). Some authorities recommend q 2 hr application. Avoid contact with eyes or damaged skin. Supplied as Zostrix® (0.25% capsaicin) or Zostrix-HP® (0.75%).

Used topically, capsaicin aids in controlling peripheral nerve pain.

[[Supraorbital and supratrochlear neuralgia]].

For [[postherpetic neuralgia]] of questionable efficacy.

Suprascapular nerve: In cases where a mass is not the underlying cause, initial treatment consists of resting the affected UE, PT (including gentle conditioning), NSAIDs, topical capsaicin cream, and sometimes corticosteroid injection.

[[Meralgia paresthetica]]: capsaicin ointment applied TID .

[[Diabetic neuropathy]]: effective in some.

Trigeminal neuralgia: 1 gm applied TID for several days resulted in remission of symptoms in 10
of 12 patients (4 relapsed in < 4 mos, but remained pain free for 1 yr after 2nd course)
((Fusco BM, Alessandri M. Analgesic Effect of Capsaicin in Idiopathic Trigeminal Neuralgia. Anesth Analg. 1992; 74:375–377)).

===== Case series =====
A total of 53 patients with hemorrhagic stroke were included. Results showed no statistically significant difference in [[cough reflex]] in both groups after the [[intervention]] (p > .05). The degree of [[cough]] in the [[intervention]] group was stronger than that in the control group (p = .046). No statistically significant difference was observed in the number of patients with [[swallowing reflex]] in response to water between the groups (p > .05). The presence/absence of post-swallow residue of the intervention group was stronger than that of the control group (p = .032). No statistically significant difference was observed between the Glasgow Coma Scale scores of the groups after the intervention (p > .05). substance P (SP) in the intervention group was significantly increased (p = .031). The Clinical Pulmonary Infection Score was significantly lower in the control group, and the difference was statistically significant (p = .028).

[[Capsaicin]] [[nebulization]] can help enhance the number of [[cough]]s in response to capsaicin, reduce post-swallow residue, and increase the level of [[substance P]] (SP) in patients with a [[hemorrhagic stroke]] which has a positive effect on pulmonary [[inflammation]]. This study provides intervention points for cough and [[swallowing]] rehabilitation after a hemorrhagic stroke
((Chao W, You-Qin M, Hong C, Hai-Ying Z, Yang-Li, Su-Xue J, Lan X, Zhong W. Effect of Capsaicin Atomization on Cough and Swallowing Function in Patients With Hemorrhagic Stroke: A Randomized Controlled Trial. J Speech Lang Hear Res. 2023 Jan 30:1-10. doi: 10.1044/2022_JSLHR-22-00296. Epub ahead of print. PMID: 36716393.)).